Testing magnesium treatment for low magnesium during hospital stays
Part of Hormones & metabolism clinical trials.
This trial studies whether giving magnesium helps people who are hospitalized with low magnesium levels. It may help correct low magnesium and improve how patients feel and recover.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older and are currently admitted to an internal medicine hospital ward
- Your blood test shows low magnesium (1.9 mg/dL or lower)
- You are able to understand the study and sign consent
- You are not in a critical condition or expected to die soon
- You are not on dialysis or have very advanced kidney disease (eGFR under 15)
- You are not already taking magnesium supplements
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks for substances in urine that might help doctors understand and diagnose low magnesium levels. If you have had low magnesium in the past, this research could lead to better detection.
This trial tests whether giving magnesium as part of a standard hospital protocol can lower the risk of irregular heartbeat and improve survival in patients admitted to the intensive care unit.
This trial tests if a magnesium supplement can raise magnesium levels in red blood cells. It is for adults with low magnesium who are willing to stop other magnesium supplements and get blood drawn.
This Phase 2 study tests MLD10 to help people with type 2 diabetes who have low magnesium levels. If you qualify, you may receive the study treatment to see if it improves magnesium-related health in a safe way.
This trial is for people already enrolled in the OMAGOD pilot study. It tests whether changing the amount of magnesium in a special dialysis fluid can reduce unwanted blood clotting and inflammation during dialysis.
This trial compares a higher dose of magnesium given through an IV to the standard dose for treating severe asthma attacks in the emergency room. It aims to see if the higher dose helps patients breathe better faster.
Hear when a new Hypomagnesemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.